Announcements
New COV-IRT Paper just Published In Science Translational Medicine on SARS-CoV-2 Targeting the Mitochondria!!
New COV-IRT Paper just Published In Science Translational Medicine on SARS-CoV-2 Targeting the Mitochondria!! New COV-IRT paper published in Science Translational Medicine titled: Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human [...]
Long COVID and Cancer Conclave Meeting on May 12th!
Long COVID and Cancer Conclave NO ONE LEFT ALONE (NOLA) www.nooneleftalone.org Co-Chairs: Kashyap Patel, MD and Afshin Beheshti, PhD May 12, 2023, Charlotte, NC Please join world's leading experts as they explore the associations between [...]
Read the newly published paper in Science Advances on the COVID-19 Exposures Assessment Tool (CEAT)!!!
COVID-19 Exposure Assessment Tool (CEAT): Exposure quantification based on ventilation, infection prevalence, group characteristics, and behavior A newly published paper is now available from COV-IRT members in Science Advances that is on our COVID-19 Exposure [...]
Read our newly accepted comprehensive review on COVID-19, the first of a 3 part series!!
Recently accepted COV-IRT member led comprehensive review of intracellular drivers in SARS-CoV-2 Infection Read the first review of a 3 part COVID-19 review series led by COV-IRT members. This first review focuses on what is [...]
Read our newly accepted from COV-IRT on how lncRNAs are involved with SARS-CoV-2 infections!!
Read our newly accepted paper on the impact of lncRNAs with SARS-CoV-2 infection! This work was driven by COV-IRT member Dr. Francisco J. Enguita! Click here to download and read the paper:
A Unique Collaboration
This unique collaborative team brings together all the capabilities needed to address the COVID-19 pandemic – computational expertise, clinical experience, advanced laboratory proficiency, and a deep knowledge of human and coronavirus genetics.
COV-IRT Project Goals:
Enhance public datasets to reveal host infection dynamics for SARS-CoV-2 to improve medical treatment options for COVID-19 patients and Long COVID patients.
Determine and design optimal targets for therapeutics against SARS-CoV-2 and Long COVID
Creating new drug delivery systems based on targets
Test newly developed therapeutics in both in vitro and in vivo SARS-CoV-2 and Long COVID models
Apply for human clinical trials
Use our established knowledge and methods for other viruses and future pandemics
Team Members
COV-IRT was founded by Dr. Afshin Beheshti, Dr. Todd Treangen, and Dr. Krista Ternus and is led by Dr. Beheshti. Members include scientists and experts from across the world, directors from both academic institutions and hospitals, senior and junior faculty, leaders from industry, graduate students, and postdocs.
The Latest from the Newsroom
The COVID-19 International Research Team is already producing interesting analyses that can potentially bring mechanistic understanding of SARS-CoV-2 and help identify therapies. Visit the Newsroom for media coverage, research updates, upcoming events, and resources.
Some News Articles Highlighting the Large Collaborative Work from COV-IRT on SARS-CoV-2 targeting the Mitochondrial
Some News Articles Highlighting the Large Collaborative Work from COV-IRT on SARS-CoV-2 targeting the Mitochondrial Here are a few news items discussing COV-IRT's paper on SARS-CoV-2 targeting the mitochondria
New COV-IRT Paper just Published In Science Translational Medicine on SARS-CoV-2 Targeting the Mitochondria!!
New COV-IRT Paper just Published In Science Translational Medicine on SARS-CoV-2 Targeting the Mitochondria!! New COV-IRT paper published in Science Translational Medicine titled: Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human [...]
Long COVID and Cancer Conclave Meeting on May 12th!
Long COVID and Cancer Conclave NO ONE LEFT ALONE (NOLA) www.nooneleftalone.org Co-Chairs: Kashyap Patel, MD and Afshin Beheshti, PhD May 12, 2023, Charlotte, NC Please join world's leading experts as they explore the associations between [...]